BIOTECH
Basket of biotechs most likely to benefit from advances in AI in 2025
While AI has driven rapid gains in semiconductors, its impact on the real economy is lagging, especially in biotech. Here, we present an equal-weighted basket of seven biotechs, up 38% in the past year, including Alnylam and Sarepta, expected to benefit from AI in 2025.